Fresenius agrees to $250 million settlement in class action lawsuits over heart attacks linked to dialysis drugs GranuFlo and NaturaLyte
Fresenius Medical Care has agreed to a $250 million settlement in a multidistrict litigation (MDL) in Massachusetts over two dialysis drugs, GranuFlo and NaturaLyte. Multiple class action lawsuits had been filed against Fresenius over allegations that the company did not adequately warn patients about a potential increased risk of heart attack or stroke linked to…